The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Ichihara, E; Harada, D; Inoue, K; Sato, K; Hosokawa, S; Kishino, D; Watanabe, K; Ochi, N; Oda, N; Hara, N; Hotta, K; Maeda, Y; Kiura, K

Ichihara, E (corresponding author), Okayama Univ Hosp, Dept Allergy & Resp Med, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.

LUNG CANCER, 2020; 139 (): 140

Abstract

Objectives: : Body mass index (BMI) is reported to be associated with the efficacy of immune checkpoint inhibitors (ICIs) in solid tumors such as mela......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索